domperidone has been researched along with Psychotic Disorders in 4 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Excerpt | Relevance | Reference |
---|---|---|
"Domperidone is a dopamine D₂ receptor antagonist that does not usually cross the blood-brain barrier." | 5.37 | Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. ( Bocti, C; Hottin, P; Landry, J; Roy-Desruisseaux, J; Tessier, D; Trudel, JF, 2011) |
"Halopemide is a new psychotropic agent, a structural analogue of the neuroleptics of the butyrophenone type but with different pharmacological and clinical properties." | 2.37 | Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions. ( Loonen, AJ; Soudijn, W, 1985) |
"Domperidone is a dopamine D₂ receptor antagonist that does not usually cross the blood-brain barrier." | 1.37 | Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. ( Bocti, C; Hottin, P; Landry, J; Roy-Desruisseaux, J; Tessier, D; Trudel, JF, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roy-Desruisseaux, J | 1 |
Landry, J | 1 |
Bocti, C | 1 |
Tessier, D | 1 |
Hottin, P | 1 |
Trudel, JF | 1 |
Johnson, TW | 1 |
Polger, S | 1 |
Emerich, DF | 1 |
Freeman, TB | 1 |
Cahill, DW | 1 |
Sanberg, PR | 1 |
Nerozzi, D | 1 |
Magnani, A | 1 |
Sforza, V | 1 |
Scaramucci, E | 1 |
Cerilli, M | 1 |
Moretti, C | 1 |
Frajese, G | 1 |
Antonozzi, I | 1 |
Meltzer, HY | 1 |
Loonen, AJ | 1 |
Soudijn, W | 1 |
1 review available for domperidone and Psychotic Disorders
Article | Year |
---|---|
Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.
Topics: Animals; Brain; Domperidone; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Psychotic Disorder | 1985 |
3 other studies available for domperidone and Psychotic Disorders
Article | Year |
---|---|
Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia.
Topics: Aged; Blood-Brain Barrier; Dementia; Domperidone; Dopamine Antagonists; Dopamine D2 Receptor Antagon | 2011 |
Neuroleptic dysphoria: in search of an animal model.
Topics: Brain; Depressive Disorder; Domperidone; Haloperidol; Humans; Psychotic Disorders | 1993 |
Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
Topics: Acute Disease; Adult; Brain; Domperidone; Humans; Male; Military Personnel; Prolactin; Psychotic Dis | 1990 |